Fidelity Investments’s American Renal Associates Holdings, Inc ARA Stock Holding History

Fidelity Investments’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-610,707	Closed	-$11.5M	–	2760
2018 Q1	$11.5M	Sell	610,707 -26,464	-4%	-$522K	﹤0.01%	1922
2017 Q4	$11.1M	Sell	637,171 -1,899,900	-75%	-$26.2M	﹤0.01%	1921
2017 Q3	$38M	Sell	2,537,071 -962,850	-28%	-$15.1M	﹤0.01%	1432
2017 Q2	$64.9M	Sell	3,499,921 -489,657	-12%	-$8.51M	0.01%	1182
2017 Q1	$67.3M	Buy	3,989,578 +500,624	+14%	+$9.99M	0.01%	1159
2016 Q4	$74.2M	Buy	3,488,954 +1,267,561	+57%	+$26M	0.01%	1133
2016 Q3	$40.6M	Buy	2,221,393 +379,936	+21%	+$8.57M	0.01%	1387
2016 Q2	$53.3M	Buy	+1,841,457	New	+$51.2M	0.01%	1250

Other funds holding ARA

Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments's ARA Position: Q2 2018 in Review

Fidelity Investments sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2018, closing a stake of 610,707 shares — an estimated $11.5M sold.

Fidelity Investments first reported a position in ARA in Q2 2016 and held it in 8 quarters. The position peaked at $74.2M in Q4 2016. 80 funds tracked by Wall St. Rank hold ARA as of Q2 2018.

Fidelity Investments reported no remaining American Renal Associates Holdings, Inc position as of Q2 2018 after selling out during the quarter.
Fidelity Investments sold 610,707 American Renal Associates Holdings, Inc shares in Q2 2018, an estimated $11.5M.
Fidelity Investments first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 8 quarters.
Fidelity Investments's American Renal Associates Holdings, Inc position peaked at $74.2M in Q4 2016.
80 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2018.

Based on Fidelity Investments's 13F filing for Q2 2018, filed 10 Aug 2018.